Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Eichler

Showing results (51-60 of 266) with videos related to

Pageof 27
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Application of the minimal trauma tissue biopsy to transdermal clinical pharmacokinetic studiesC Schrolnberger, M Brunner, B X Mayer, et al.
Critical Care Medicine|July 13, 2000
Surgery and intensive care procedures affect the target site distribution of piperacillinM Brunner, T Pernerstorfer, B X Mayer, et al.
Human Antibodies and Hybridomas|January 1, 1990
Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanomaR F Martin, R Kisor, D Schroer, et al.
Electrophoresis|June 1, 2000
Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteersB X Mayer, U Hollenstein, M Brunner, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 1998
Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to ratsC P Luftensteiner, I Schwendenwein, B Paul, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Cardiocirculatory effects of moclobemide (Ro 11-1163), a new reversible, a short-acting MAO-inhibitor with preferential type A inhibition, in healthy volunteers and depressive patientsS Gasic, A Korn, H G Eichler, et al.
British Journal of Clinical Pharmacology|December 1, 1988
Venous responsiveness to atrial natriuretic factor in manG A Ford, H G Eichler, B B Hoffman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Poly(I).poly(C), a potential drug carrier for the antitumor agent mitoxantrone: in vitro drug binding studyH G Eichler, R Mader, B Blöchl-Daum, et al.
The American Journal of Physiology|December 1, 1996
Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance testM Müller, A Holmäng, O K Andersson, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Absence of interaction between tenoxicam and warfarinH G Eichler, M Jung, P A Kyrle, et al.
Pageof 27

Showing results (51-60 of 266) with videos related to

Sort By:
Pageof 27
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Application of the minimal trauma tissue biopsy to transdermal clinical pharmacokinetic studiesC Schrolnberger, M Brunner, B X Mayer, et al.
Critical Care Medicine|July 13, 2000
Surgery and intensive care procedures affect the target site distribution of piperacillinM Brunner, T Pernerstorfer, B X Mayer, et al.
Human Antibodies and Hybridomas|January 1, 1990
Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanomaR F Martin, R Kisor, D Schroer, et al.
Electrophoresis|June 1, 2000
Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteersB X Mayer, U Hollenstein, M Brunner, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 1998
Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to ratsC P Luftensteiner, I Schwendenwein, B Paul, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Cardiocirculatory effects of moclobemide (Ro 11-1163), a new reversible, a short-acting MAO-inhibitor with preferential type A inhibition, in healthy volunteers and depressive patientsS Gasic, A Korn, H G Eichler, et al.
British Journal of Clinical Pharmacology|December 1, 1988
Venous responsiveness to atrial natriuretic factor in manG A Ford, H G Eichler, B B Hoffman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Poly(I).poly(C), a potential drug carrier for the antitumor agent mitoxantrone: in vitro drug binding studyH G Eichler, R Mader, B Blöchl-Daum, et al.
The American Journal of Physiology|December 1, 1996
Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance testM Müller, A Holmäng, O K Andersson, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Absence of interaction between tenoxicam and warfarinH G Eichler, M Jung, P A Kyrle, et al.
Pageof 27